4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-031539
Chief Financial Officer sold 50,000 shares at $40.00 ($2,000,000)
- Chief Financial Officer acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Cohen Chad M · Chief Financial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-05-19 | Exercise or conversion : show line 1 in the form | +30,000 | $4.07 | $122,100 | 31,000 | D |
| 2020-05-19 | Exercise or conversion : show line 2 in the form | +20,000 | $6.32 | $126,400 | 51,000 | D |
| 2020-05-19 | Sale : show line 3 in the form | −50,000 | $40.00 | $2,000,000 | 1,000 | D |
| Open-market sales · 50,000 sh · avg $40.00 · $2,000,000 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-05-19 | Exercise or conversion : show line 4 in the form Stock Option (Right To Buy) | −20,000 | 700,000 | D |
| 2020-05-19 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −30,000 | 0 | D |
Loading xslF345X03/doc4.xml…